IRONWOOD PHARMACEUTICALS, INC. Increase (Decrease) in Other Operating Liabilities
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Increase (Decrease) in Other Operating Liabilities of -$661.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2017-02-22
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2013-09-30 was $0.00.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2013-06-30 was $744.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2013-03-31 was -$83.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2014 was -$661.00K.
- IRONWOOD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2012 was $992.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$661.00K 10-K · filed 2017-02-22 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $744.00K derived: sum of 2 quarters · filed 2014-11-05 | $661.00K 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $744.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $661.00K 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | -$83.00K 10-Q · filed 2014-04-29 | |||
| 2012-12-31 | $992.00K 10-K · filed 2015-02-18 | |||
| 2011-06-30 | $897.00K 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |